🇺🇸 HX575 recombinant human erythropoietin alfa in United States

HX575 recombinant human erythropoietin alfa (HX575 recombinant human erythropoietin alfa) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

HX575 recombinant human erythropoietin alfa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HX575 recombinant human erythropoietin alfa approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for HX575 recombinant human erythropoietin alfa in United States?

Sandoz is the originator. The local marketing authorisation holder may differ — check the official source linked above.